Skip to main content

Breadcrumb

  1. Home

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, ALCHEMIST Chemo-IO Study

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, ALCHEMIST Chemo-IO Study

Registry of Asthma Patients Initiating DUPIXENT®

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Registry of Asthma Patients Initiating DUPIXENT®

Testing the Addition of the Pill Chemotherapy, Cabozantinib, to the Standard Immune Therapy Nivolumab Compared to Standard Chemotherapy for Non-small Cell Lung Cancer

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Testing the Addition of the Pill Chemotherapy, Cabozantinib, to the Standard Immune Therapy Nivolumab Compared to Standard Chemotherapy for Non-small Cell Lung Cancer

Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients Who Present With Symptomatic Heart Failure With Reduced Ejection Fraction (HFrEF): The CORCINCH-HF Study

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients Who Present With Symptomatic Heart Failure With Reduced Ejection Fraction (HFrEF): The CORCINCH-HF Study

FUnctional diagnoSIs of corONary Stenosis (FUSION)

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about FUnctional diagnoSIs of corONary Stenosis (FUSION)

Study With Afuresertib and Paclitaxel in Platinum Resistant Ovarian

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Study With Afuresertib and Paclitaxel in Platinum Resistant Ovarian

A Study of TAK-981 Given With Pembrolizumab in Participants With Select Advanced or Metastatic Solid Tumors

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about A Study of TAK-981 Given With Pembrolizumab in Participants With Select Advanced or Metastatic Solid Tumors

Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors

Actigraphy Improvement With Voxelotor (ActIVe) Study

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Actigraphy Improvement With Voxelotor (ActIVe) Study

TTVR Early Feasibility Study

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about TTVR Early Feasibility Study

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 206
  • Page 207
  • Page 208
  • Page 209
  • Page 210
  • Page 211
  • Page 212
  • Page 213
  • Page 214
  • …
  • Next page Next
  • Last page Last
Subscribe to